首页> 外文期刊>Open Access Library Journal >Virological Profile of Patients Infected with HIV Starting Antiretroviral Treatment in Kinshasa
【24h】

Virological Profile of Patients Infected with HIV Starting Antiretroviral Treatment in Kinshasa

机译:在金沙萨开始抗逆转录病毒治疗的艾滋病毒感染者的病毒学概况

获取原文
       

摘要

Background: Viral Load (VL), CD4 T cells count and clinical signs are significant parameters for the decision of starting ARV Treatment (ART). The aim of this study is to determine the Viral Load profile of eligible patients on treatment in the centers according to the algorithm used in Kinshasa and the DRC. Methodology: Our sample consisted of 153 HIV-positive patients naive of ART. All patients aged over 18 years were included in the study without gender discrimination. The determination of the VL was made at the laboratory of Molecular Biology of the Faculty of Medicine of the University of Kinshasa using a previously described technique. Results: Of the 153 patients included in the study, 92 (60.1%) were women. The age of the patients was in the range 18 - 65 years with a mean of 37 years. Most patients (91.5%) were clinical stage 3, while the rest (8.5%) were clinical stage 4 for HIV infection. The rates of CD4 T lymphocytes were between 8 and 915 cells/mm ~( 3 ) with a median value of 180 cells/mm ~( 3 ) . Seventy nine patients (86.8%) had CD4 count below 500 cells/mm ~( 3 ) . The median VL of patients is 5.68 log _( 10 ) RNA copies/ml. The minimum and maximum values are respectively 0.37 and 7.95 log _( 10 ) RNA copies/ml. Conclusion: The majority of patients (63.4%) in Kinshasa begin antiretroviral treatment with a poor prognosis. The Viral loads are usually very high in these patients and CD4 quite collapsed. Indeed, the median value of CD4 for the patients is 180 cells/mm ~( 3 ) for the population, while the mean value of Viral Load is 5.48 log _( 10 ) RNA copies/ml.
机译:背景:病毒载量(VL),CD4 T细胞计数和临床体征是决定开始ARV治疗(ART)的重要参数。这项研究的目的是根据金夏沙(Kinshasa)和DRC中使用的算法,确定在中心接受治疗的合格患者的病毒载量曲线。方法:我们的样本包括153位未接受抗病毒治疗的HIV阳性患者。所有年龄超过18岁的患者均被纳入研究,没有性别歧视。 VL的测定是在金沙萨大学医学院分子生物学实验室使用先前描述的技术进行的。结果:纳入研究的153名患者中,有92名(60.1%)是女性。患者年龄在18-65岁之间,平均37岁。大多数患者(91.5%)处于3期临床,而其余患者(8.5%)则是4级艾滋病毒感染。 CD4 T淋巴细胞的发生率在8到915细胞/ mm〜(3)之间,中位数为180细胞/ mm〜(3)。 79例患者(86.8%)的CD4计数低于500个细胞/ mm〜(3)。患者的VL中位数为5.68 log _(10)RNA复制/ ml。最小值和最大值分别是0.37和7.95 log _(10)RNA拷贝/ ml。结论:金沙萨的大多数患者(63.4%)开始抗逆转录病毒治疗,预后较差。这些患者的病毒载量通常很高,而CD4则相当虚弱。实际上,患者的CD4的中位数为该人群的180个细胞/ mm〜(3),而病毒载量的平均值为5.48 log _(10)RNA复制/ ml。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号